Which Neil Woodford fund should you buy for your ISA?

All three of Neil Woodford’s funds have attractive qualities.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Neil Woodford is widely considered to be the UK’s best fund manager. So if you’re looking for a fund manager that you can trust to take care of your wealth, Woodford is usually a safe bet.

He currently manages three funds, which target different areas of the market and are suitable for various types of investors.

And even though Woodford manages all three, his style of investing for them differs significantly, as each one has a different set of goals and objectives.

The all-rounder 

The CF Woodford Equity Income fund was the first one Woodford set up after leaving his former employer Invesco to set out on his own several years ago. 

The equity income fund is not, as its name suggests, a pure income fund. Instead, it aims to achieve both income and capital growth, which means that Woodford can invest across the investment spectrum. Everything from early-stage private biotech companies to the UK’s largest pharmaceutical companies can be found in the portfolio and while the fund’s dividend yield of 3.2% may be below the FTSE 100 average, the potential for capital growth more than makes up for the lack of income.

Due to its diversification and growth as well as income focus, the Equity Income fund is suitable for every investor, especially those just starting out on their investment career as, over the long-term, this fund should generate some impressive returns.

High risk, high reward 

Woodford’s Patient Capital Trust may not be suitable for the most risk-averse investors. Its portfolio provides exposure to a mix of exciting, disruptive, early-stage and early-growth companies, together with some of Woodford’s high conviction mid and large capitalisation ideas. The combination of small and large-cap companies means Patient Capital isn’t as risky as venture capital-style funds, but it’s not going to make you rich overnight.

Investors who are not prepared to take any risk with their money, or put their capital at risk might do best to avoid this opportunity, and those investors who are unwilling to invest for five years or more should also look elsewhere. Nonetheless, if you’re still decades from retirement and are looking for a high-risk, high-reward opportunity, managed by one of the UK’s best fund managers, The Patient Capital trust may be for you.

Income focus 

Lastly, there’s the Woodford Income Focus Fund, which is now available for investment with the launch period closing at midday on 12 April. 

This fund is targeting an income of 5p per share per annum, with the prospect of modest, sustainable income growth in the years following. Unlike the other two, the Income Focus Fund will only invest in quoted stocks meaning that this opportunity may be more suitable for the risk-averse investor who is looking to generate income with minimal chance of losing money.

Up to you

Overall, the decision of which Woodford fund to buy for your ISA comes down to your own risk preference. Income seekers who prefer to play it safe should buy the new income fund, while income hunters with a long-term outlook could consider the Equity Income fund. Investors with the highest risk tolerance may want to take a look at Woodford’s Patient Capital trust.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »